Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A 10-year population-based study of people with multiple sclerosis in Stockholm, Sweden: use of and satisfaction with care and the value of different factors in predicting use of care.
Central neuropathic pain in MS is due to distinct thoracic spinal cord lesions.
Inhibition of Epidermal Growth Factor Receptor Improves Myelination and Attenuates Tissue Damage of Spinal Cord Injury.
A rare association of tuberculous longitudinally extensive transverse myelitis (LETM) with brain tuberculoma.
Fatigue in multiple sclerosis: The contribution of occult white matter damage.
Frontrunners of T cell activation: Initial, localized Ca2+ signals mediated by NAADP and the type 1 ryanodine receptor.
Mode of action and clinical studies with fumarates in multiple sclerosis.
Complement receptor 2 is up regulated in the spinal cord following nerve root injury and modulates the spinal cord response.
ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration.
Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.
[NLRP3 inflammasome and multiple sclerosis/EAE].
Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation.
The progress of cognitive decline in newly diagnosed MS patients.
Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
A MS-lesion pattern discrimination plot based on geostatistics.
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature.
Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4.
Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems.
Development of Gene Transfer for Induction of Antigen-specific Tolerance.
Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
Lower urinary tract symptoms associated with neurological conditions: Observations on a clinical sample of outpatients neurorehabilitation service.
A GPBAR1 (TGR5) Small Molecule Agonist Shows Specific Inhibitory Effects on Myeloid Cell Activation In Vitro and Reduces Experimental Autoimmune Encephalitis (EAE) In Vivo.
Overexpression of CD44 in Neural Precursor Cells Improves Trans- Endothelial Migration and Facilitates Their Invasion of Perivascular Tissues In Vivo.
Olanzepine-induced neuroleptic malignant syndrome in a case of multiple sclerosis.
Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.

Pages